Arcadia Biosciences, Inc. (RKDA) Cash flow
Market cap
$2.52M
P/E ratio
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 717,000 | 1 |
| Cash from operations | -15 | -17 | -14 | -14 | -17 | -30 | -26 | -14 | -15 | -10 |
| Capital expenditures | -0 | -0 | -0 | -0 | -1 | -2 | -1 | -0 | -0 | -0 |
| Cash from investing | -46 | -5 | 47 | -6 | -8 | 17 | 17 | 1 | -4 | 7 |
| Cash from financing | 69 | 0 | -26 | 22 | 22 | 21 | 22 | 5 | 6 | 0 |
| Free cash flow | ||||||||||
| FCF margin (%) | - | - |